• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EXACTECH, INC. NV GXL LINER LIPPED 40MM ID, GROUP 4 CUPS; PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/POLYMER, CEMENTED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EXACTECH, INC. NV GXL LINER LIPPED 40MM ID, GROUP 4 CUPS; PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/POLYMER, CEMENTED Back to Search Results
Catalog Number 132-40-54
Medical Device Problem Code Naturally Worn (2988)
Health Effect - Clinical Codes Failure of Implant (1924); Insufficient Information (4580)
Date of Event 10/24/2023
Type of Reportable Event Serious Injury
Event or Problem Description
The patient had an original exactech primary total hip replacement on (b)(6) 2017 by dr.(b)(6).The patient returned to dr.Williams's office having been notified of originally being implanted with a recalled hip poly liner.The patient was booked for revision tha possible femoral head and acetabular poly liner swap on (b)(6) 2023.The patient had a femoral head and poly liner swap.It was noted that the removed recalled liner showed early abnormal eccentric wear.The patient left the or stable.During this case the femoral head impactor tip had a piece that broke off of it when using the instrument to disengage the femoral head from the neck taper.Pictures of the broken instrument are attached.It will be returned and a new one ordered to replace it.
 
Additional Manufacturer Narrative
Section h10: (h3) pending evaluation (d10) concomitant device(s): 4881184 186-01-60 - integrip cc, cluster 60mm, g4.4884382 170-40-00 - biolox delta femoral 40mm od, +0mm.4917680 190-20-11 - alt ha s noclr std sz 11.
 
Additional Manufacturer Narrative
H3: based on the available information, the patient involved meets the following risk criteria for early prosthesis wear as specified in the hhe: combination of largest available femoral head and/or thinnest available acetabular liner was used.The most likely underlying cause for the revision due to early prosthesis wear reported is a combination of risk factors specified in the hhe.However, this cannot be confirmed from the reported information and the devices were not available for evaluation.
 
Additional Manufacturer Narrative
Based on the available information, the patient meets the following risk criteria for early prosthesis wear and/or osteolysis: implanted with a lateralized liner, combination of largest available femoral head and/or thinnest available acetabular liner was used, and implanted with a component having a shelf age of greater than 2 years.The most likely cause for the reported revision due to prosthesis wear and osteolysis may have been a combination of risk factors such as use error, implant positioning, implant size selection, and patient factors (fitness for surgery, biomechanics, activity level and local tissue oxidation potential).However, this cannot be confirmed as the devices were not returned for evaluation, and images and radiographs were not provided.H6: corrected health effect, component, and investigation clinical codes.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NV GXL LINER LIPPED 40MM ID, GROUP 4 CUPS
Common Device Name
PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/POLYMER, CEMENTED
Manufacturer (Section D)
EXACTECH, INC.
2320 nw 66 court
gainesville FL 32653
Manufacturer (Section G)
EXACTECH, INC.
2320 nw 66 ct
gainesville FL 32653
Manufacturer Contact
geoff gannon
2320 nw 66 ct
gainesville, FL 32653
3523771140
MDR Report Key18140311
Report Number1038671-2023-02781
Device Sequence Number18138085
Product Code JDI
UDI-Device Identifier10885862207050
UDI-Public10885862207050
Combination Product (Y/N)N
Initial Reporter StateIN
Initial Reporter CountryUS
PMA/510(K) Number
K121392
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2017
Device Explanted Year2023
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Remedial Action Recall
Type of Report Initial,Followup,Followup
Report Date (Section B) 12/11/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date03/17/2021
Device Catalogue Number132-40-54
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 10/25/2023
Supplement Date Received by Manufacturer03/04/2024
12/11/2024
Initial Report FDA Received Date11/15/2023
Supplement Report FDA Received Date03/21/2024
12/11/2024
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured03/18/2016
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
If action reported to FDA under 21 USC 360i(g), list
FDA-assigned Recall Number or include a statement
Z-1732-2022
Patient Sequence Number1
Patient Age57 YR
Patient SexMale
Patient Weight140 KG
-
-